Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Assets Average (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Assets Average for 3 consecutive years, with $598.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average rose 7.57% to $598.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $598.2 million, a 7.57% increase, with the full-year FY2025 number at $567.7 million, down 2.29% from a year prior.
  • Assets Average was $598.2 million for Q4 2025 at Nuvation Bio, down from $624.4 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $649.2 million in Q2 2023 to a low of $516.6 million in Q1 2025.
  • A 3-year average of $598.3 million and a median of $604.0 million in 2024 define the central range for Assets Average.
  • Biggest YoY gain for Assets Average was 7.57% in 2025; the steepest drop was 16.32% in 2025.
  • Nuvation Bio's Assets Average stood at $626.2 million in 2023, then dropped by 11.19% to $556.1 million in 2024, then increased by 7.57% to $598.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Assets Average are $598.2 million (Q4 2025), $624.4 million (Q3 2025), and $569.9 million (Q2 2025).